Abstract
In an article in this issue of Clinical Cancer Research , Yasui et al. ([1][1]) suggest that cyclin D1 may play a role in maintaining vascular endothelial growth factor (VEGF) expression and that antisense cyclin D1 could be useful for targeting cancer cells and tumor vessels. Tumor growth and
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
